Virbac USA veterinary site
Note, content for veterinary professionals only.

MOVOFLEX® Advanced Soft Chews Joint Supplement for dogs

Advance your recommendation for hip and joint support with new MOVOFLEX® Advanced Soft Chews, now with krill oil and more to help sustain your canine patients’ joint health through all life stages.

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-2-970x400.png

 

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-3-970x120.png

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-4-250x250.png

 

  • Support for overall hip and joint structure and flexibility, as well as bone health
  • Complete balance of ingredients with synergistic functions, now including:
    • Krill oil, providing omega-3 fatty acids to help lubricate joints1,2
    • Low molecular weight hyaluronic acid, shown to support joint health3,4
  • Positive results within as little as seven days5 with no loading dose

 

 

 

 

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-5-970x120.png

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-6-350x350.pngAstaxanthin
Powerful antioxidant: Supports joint health with protection from free radicals and nitrous oxide6

Boswellic acids
Derived from Boswellia serrata, an ingredient known to help decrease normal inflammatory pathways:7 Supports structural integrity of joints and connective tissues

BiovaFlex® Eggshell Membrane
Membrane from eggshells includes chondroitin sulfate, collagen and elastin: Supports joint structure and flexibility

Vitamin D3
Synthetic ingredient: Supports bone health

High molecular weight hyaluronic acid
Produced via bacterial fermentation: Supports joint flexibility and viscosity of synovial fluids7,8

NEW! Krill oil
Sustainably sourced Antarctic krill, which contains omega-3 fatty acids: Helps lubricate joints

Synergistic effect: Contains omega-3 fatty acids in a form bound to phospholipids, helping improve the absorption capabilities of astaxanthin and hyaluronic acid1,2

NEW! Low molecular weight hyaluronic acid
Produced via bacterial fermentation: Supports joint structure and joint maintenance3,4

Synergistic effect: Shown to support joint health in combination with krill oil and astaxanthin3,4

 

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-7-970x120.png

To assess pet owner perceptions of the new formulation, we conducted a 30-day trial of MOVOFLEX® Advanced Soft Chews.5 All participating dogs were already taking the original MOVOFLEX® Soft Chews.


Pet owners completed online surveys at Days 0, 7 and 30. Perceptions assessed included:

  • Palatability
  • Ease of administering the chew
  • Effectiveness on mobility

 

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-8-250x250.pngDAY 30 RESULTS

Palatability
91% perceived it as similar to or better than the original chew5

Ease of administering
96% said it was as easy or easier to give their dog when compared with the original5

Effectiveness on mobility
63% recognized an improvement in their dog’s mobility5

Purchase interest
90% said they would purchase if recommended by a veterinarian5

 

 

VBC-14706_Movoflex-Advanced_DVM_Landing_Page-9-970x120.png

  • To order MOVOFLEX Advanced Soft Chews for your clinic, please talk with your distributor or Virbac representative
  • Your clients can order directly from iVet.com once your clinic is registered
  • Questions about getting started with iVet? Give our Sales & Customer Service team a call at 1-844-484-7222

 

Movoflex-Advanced_DVM_Landing_Page-11-970x120.png

For your healthcare team

 

For your clients

 

For your website, social media & online communications

 


 

Warnings: Not for human consumption. Keep out of the reach of children and animals. In case of accidental overdose, contact a health professional immediately.


Cautions: If animal’s condition worsens or does not improve, stop product administration and consult your veterinarian. Safe use in pregnant animals or animals intended for breeding has not been proven.


References:

  1. Mercke Odeberg J, Lignell A, Pettersson A, Höglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci. 2003;19(4):299-304. doi: 10.1016/s0928-0987(03)00135-0.
  2. Huang SL, Ling PX, Zhang TM. Oral absorption of hyaluronic acid and phospholipids complexes in rats. World J Gastroenterol. 2007;13(6):945-949. doi: 10.3748/wjg.v13.i6.945.
  3. Park DR, Ko R, Kwon SH, et al. FlexPro MD, a mixture of krill oil, astaxanthin, and hyaluronic acid, suppresses lipopolysaccharide-induced inflammatory cytokine production through inhibition of NF-κB. J Med Food. 2016;19(12):1196-1203. doi: 10.1089/
  4. jmf.2016.3787.
  5. Park MH, Jung JC, Hill S, et al. FlexPro MD®, a combination of krill oil, astaxanthin and hyaluronic acid, reduces pain behavior and inhibits inflammatory response in monosodium iodoacetate-induced osteoarthritis in rats. Nutrients. 2020;12(4):956. doi: 10.3390/nu12040956.
  6. Data on file. Virbac Corporation.
  7. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10A):58D-68D. doi: 10.1016/j.amjcard.2008.02.010.
  8. Balogh L, Polyak A, Mathe D, et al. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J Agric Food Chem. 2008;56(22):10582-10593. doi: 10.1021/jf8017029.

©2022 Virbac Corporation. All rights reserved. MOVOFLEX is a registered trademark of The Virbac Group of Companies. BIOVAFLEX is a registered trademark of Biova, LLC, used under license. 5/22 14706.01